Autosomal dominant partial epilepsy with auditory features: Difference between revisions

From WikiMD's Wellness Encyclopedia

No edit summary
Tag: visualeditor-wikitext
 
CSV import
 
Line 1: Line 1:
{{SI}}
{{Infobox medical condition
| name                    = Autosomal dominant partial epilepsy with auditory features
| image                  = [[File:Autosomal_dominant_-_en.svg|200px]]
| caption                = Autosomal dominant pattern
| field                  = [[Neurology]]
| symptoms                = [[Seizures]], [[auditory hallucinations]], [[aphasia]]
| onset                  = Childhood to early adulthood
| duration                = Lifelong
| causes                  = [[Genetic mutation]]
| risks                  = Family history of epilepsy
| diagnosis              = [[Electroencephalogram|EEG]], [[genetic testing]]
| differential            = [[Temporal lobe epilepsy]], [[focal epilepsy]]
| treatment              = [[Anticonvulsant]] medications
| prognosis              = Generally good with treatment
| frequency              = Rare
}}
== '''Alternate names''' ==
== '''Alternate names''' ==
ADLTE; ADPEAF; [[Autosomal dominant]] lateral [[temporal lobe epilepsy]]; ETL1  
ADLTE; ADPEAF; [[Autosomal dominant]] lateral [[temporal lobe epilepsy]]; ETL1  
== '''Definition''' ==
== '''Definition''' ==
Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of [[epilepsy]], a condition that is characterized by recurrent [[seizures]].
Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of [[epilepsy]], a condition that is characterized by recurrent [[seizures]].
== '''Epidemiology''' ==
== '''Epidemiology''' ==
This condition appears to be uncommon, although its prevalence is unknown.  
This condition appears to be uncommon, although its prevalence is unknown.  
== '''Cause''' ==
== '''Cause''' ==
* ADPEAF is caused by changes (mutations) in the '''LGI1 or RELN gene'''.
* ADPEAF is caused by changes (mutations) in the '''LGI1 or RELN gene'''.
* This gene provides instructions for making a''' protein called Lgi1 or epitempin''', which is found primarily in nerve cells ([[neurons]]) in the brain.  
* This gene provides instructions for making a''' protein called Lgi1 or epitempin''', which is found primarily in nerve cells ([[neurons]]) in the brain.  
* Although researchers have proposed several functions for this protein, its precise role in the brain remains uncertain.
* Although researchers have proposed several functions for this protein, its precise role in the brain remains uncertain.
== '''Gene mutations''' ==
== '''Gene mutations''' ==
* Mutations in the LGI1 gene likely '''disrupt the function of epitempin'''.  
* Mutations in the LGI1 gene likely '''disrupt the function of epitempin'''.  
Line 19: Line 32:
* In the remaining families, the cause of the condition is unknown.  
* In the remaining families, the cause of the condition is unknown.  
* Researchers are searching for other genetic changes that may underlie the condition.
* Researchers are searching for other genetic changes that may underlie the condition.
== '''Inheritance''' ==
== '''Inheritance''' ==
[[File:Autosomal dominant - en.svg|thumb|right|Autosomal dominant pattern, a 50/50 chance.]]
This condition is inherited in an [[autosomal dominant]] manner.
This condition is inherited in an [[autosomal dominant]] manner.
== '''Onset''' ==
== '''Onset''' ==
Signs and symptoms of the condition generally begin in adolescence or early adulthood.
Signs and symptoms of the condition generally begin in adolescence or early adulthood.
== '''Signs and symptoms''' ==
== '''Signs and symptoms''' ==
* In ADPEAF, specifically, most affected people experience secondary generalized [[seizures]] and partial seizures, some of which are associated with sound-related symptoms (such as buzzing, humming, or ringing) and/or receptive [[aphasia]] (inability to understand written or spoken words).  
* In ADPEAF, specifically, most affected people experience secondary generalized [[seizures]] and partial seizures, some of which are associated with sound-related symptoms (such as buzzing, humming, or ringing) and/or receptive [[aphasia]] (inability to understand written or spoken words).  
* Less commonly, seizures may cause visual [[hallucinations]], a disturbance in the sense of smell, [[vertigo]], or other symptoms affecting the senses.
* Less commonly, seizures may cause visual [[hallucinations]], a disturbance in the sense of smell, [[vertigo]], or other symptoms affecting the senses.
== '''Diagnosis''' ==
== '''Diagnosis''' ==
* The clinical diagnosis of ADEAF is established  with characteristic clinical features, normal brain imaging ([[MRI]] or [[CT]]), and family history consistent with [[autosomal dominant]] inheritance.<ref>Michelucci R, Nobile C. Autosomal Dominant Epilepsy with Auditory Features. 2007 Apr 20 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1537/</ref>
* The clinical diagnosis of ADEAF is established  with characteristic clinical features, normal brain imaging ([[MRI]] or [[CT]]), and family history consistent with [[autosomal dominant]] inheritance.<ref>Michelucci R, Nobile C. Autosomal Dominant Epilepsy with Auditory Features. 2007 Apr 20 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews¬Æ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1537/</ref>
* Identification of a heterozygous pathogenic variant in LGI1, MICAL1, or RELN by molecular [[genetic testing]] establishes the diagnosis.
* Identification of a heterozygous pathogenic variant in LGI1, MICAL1, or RELN by molecular [[genetic testing]] establishes the diagnosis.
== '''Treatment''' ==
== '''Treatment''' ==
The [[seizures]] associated with ADPEAF are typically well controlled with medications that are used to treat [[epilepsy]] (called [[Antiepileptic drug|antiepileptic drugs]]).
The [[seizures]] associated with ADPEAF are typically well controlled with medications that are used to treat [[epilepsy]] (called [[Antiepileptic drug|antiepileptic drugs]]).
== '''References''' ==
== '''References''' ==
<references />
<references />
{{Seizures and epilepsy}}
{{Seizures and epilepsy}}
{{Medicine}}
{{Medicine}}
{{DEFAULTSORT:Temporal Lobe Epilepsy}}
{{DEFAULTSORT:Temporal Lobe Epilepsy}}
[[Category:Epilepsy types]]
[[Category:Epilepsy types]]

Latest revision as of 22:21, 5 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Autosomal dominant partial epilepsy with auditory features
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Seizures, auditory hallucinations, aphasia
Complications N/A
Onset Childhood to early adulthood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history of epilepsy
Diagnosis EEG, genetic testing
Differential diagnosis Temporal lobe epilepsy, focal epilepsy
Prevention N/A
Treatment Anticonvulsant medications
Medication N/A
Prognosis Generally good with treatment
Frequency Rare
Deaths N/A


Alternate names[edit]

ADLTE; ADPEAF; Autosomal dominant lateral temporal lobe epilepsy; ETL1

Definition[edit]

Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of epilepsy, a condition that is characterized by recurrent seizures.

Epidemiology[edit]

This condition appears to be uncommon, although its prevalence is unknown.

Cause[edit]

  • ADPEAF is caused by changes (mutations) in the LGI1 or RELN gene.
  • This gene provides instructions for making a protein called Lgi1 or epitempin, which is found primarily in nerve cells (neurons) in the brain.
  • Although researchers have proposed several functions for this protein, its precise role in the brain remains uncertain.

Gene mutations[edit]

  • Mutations in the LGI1 gene likely disrupt the function of epitempin.
  • It is unclear how the altered protein leads to seizure activity in the brain.
  • LGI1 mutations have been identified in about half of all families diagnosed with ADPEAF.
  • In the remaining families, the cause of the condition is unknown.
  • Researchers are searching for other genetic changes that may underlie the condition.

Inheritance[edit]

This condition is inherited in an autosomal dominant manner.

Onset[edit]

Signs and symptoms of the condition generally begin in adolescence or early adulthood.

Signs and symptoms[edit]

  • In ADPEAF, specifically, most affected people experience secondary generalized seizures and partial seizures, some of which are associated with sound-related symptoms (such as buzzing, humming, or ringing) and/or receptive aphasia (inability to understand written or spoken words).
  • Less commonly, seizures may cause visual hallucinations, a disturbance in the sense of smell, vertigo, or other symptoms affecting the senses.

Diagnosis[edit]

  • The clinical diagnosis of ADEAF is established with characteristic clinical features, normal brain imaging (MRI or CT), and family history consistent with autosomal dominant inheritance.<ref>Michelucci R, Nobile C. Autosomal Dominant Epilepsy with Auditory Features. 2007 Apr 20 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews¬Æ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1537/</ref>
  • Identification of a heterozygous pathogenic variant in LGI1, MICAL1, or RELN by molecular genetic testing establishes the diagnosis.

Treatment[edit]

The seizures associated with ADPEAF are typically well controlled with medications that are used to treat epilepsy (called antiepileptic drugs).

References[edit]

<references />


NIH genetic and rare disease info[edit]

Autosomal dominant partial epilepsy with auditory features is a rare disease.


This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia